International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Special Issue 3 doi: 10.5281/zenodo.8026005
Review Article
A Brief Study on Fenugreek (Trigonella Foenum-Graecum): A Review
 ,
 ,
 ,
 ,
Published
June 12, 2023
Abstract
Fenugreek (Trigonella foenum-graecum) is one of the oldest medicinal plants with exceptional medicinal and nutritional profile. Fenugreek is native to southern Europe and Asia, is an annual herb with white flowers and hard, yellowish brown and angular seeds, known from ancient times, for nutritional value beside of it medicinal effects. Fenugreek seeds contain a substantial amount of fiber, phospholipids, glycolipids, oleic acid, linolenic acid, linoleic acid, choline, vitamins A, B1, B2, C, nicotinic acid, niacin, calcium, iron and many other functional elements. Trigonella foenum-graecum was used as a traditional remedy for the treatment of various diseases. In this study after a general discussion of chemical constituents, the biological and pharmacological actions of fenugreek such as Anti-diabetic activity, Hypocholesterolaemic properties, Immunomodulatory activity, Anti-oxidant activity, Anti-cataract activity and Anti- carcinogenic activity were briefly reviewed. Current lifestyle, eating habits, stress, environmental factors and intensive use of synthetic chemicals in food processing and agriculture have radically increased the progression of several human diseases. Globally, researchers have been looking for natural therapeutic substances that can be used to treat or delay the onset of these lifestyle-related disorders. Overall, this review highlights the morphology, adaptability, nutritional constituents, and associated functionality and medicinal significance of Fenugreek.
Recommended Articles
Loading Image...
Volume-4, Special Issue 3
Citations
606 Views
254 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved